Neuroathletic Training in Adolescent Basketball Players

May 6, 2026 updated by: Gizem Gül, Pamukkale University

Effects of Neuroathletic Training on Dynamic Visual Acuity, Endurance, Balance, Kinesiophobia, and Injury Risk in Adolescent Basketball Players: A Randomized Controlled Trial

This randomized controlled study aims to investigate the effects of neuroathletic training on dynamic visual acuity, endurance, balance, and injury risk in adolescent basketball players. Licensed basketball players aged 14-17 years will be randomly assigned to either a neuroathletic training group or a control group. The training group will receive sport-specific progressive neuroathletic exercises in addition to their regular basketball training for one week, while the control group will continue their usual training routine. Before and after the intervention, participants will be assessed for dynamic visual acuity, core muscle endurance, balance, functional movement, pain, and kinesiophobia. The findings of this study may help clarify whether neuroathletic training can improve performance-related outcomes and reduce injury risk in adolescent basketball players.

Study Overview

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pamukkale/Kınıklı
      • Denizli, Pamukkale/Kınıklı, Turkey (Türkiye), 20070
        • Pamukkale University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Aged between 14 and 17 years, Being a professional or amateur basketball player, Participating in sports for at least five hours per week and having engaged in the sport for a minimum of two years, Having no cognitive or motor dysfunction, Providing written informed consent signed by the parents/legal guardians.

Exclusion Criteria:

Reporting a back or lower extremity injury within the previous six months, Having any relevant medical history or current condition that could affect the balance system or perception-action system (e.g., neurological disorders, inner ear disorders, or color blindness), Using medications or substances that could affect balance and visual-motor reaction time performance.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
Experimental: Neuroathletic Training Group
This intervention is a progressive neuroathletic training program developed by the research team to improve motor skills, balance, eye coordination, and vestibular function in adolescent basketball players. The program is performed for approximately 20 minutes per day over 6 days and includes visual relaxation exercises, eye massage, unilateral vertical jumping, Brock string training, shoulder/wrist/ankle circular movements, sacculus activation, cerebellar activation, and antisaccade exercises. The content is progressively advanced across days by integrating balance challenges and visual-vestibular tasks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional Movement Screen (FMS) total score
Time Frame: Baseline and immediately following the 1-week intervention
Assessment of injury risk and movement quality using the Functional Movement Screen total score. The test consists of 7 movement patterns scored from 0 to 3, with higher scores indicating better functional movement quality and lower injury risk.
Baseline and immediately following the 1-week intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dynamic Visual Acuity (DVA)
Time Frame: Baseline and immediately following the 1-week intervention
Dynamic visual acuity assessed using a visual chart while the participant performs active horizontal head movements. The lowest clearly read line will be recorded.
Baseline and immediately following the 1-week intervention
Balance Error Scoring System (BESS) / Denge Hata Puanlama Sistemi
Time Frame: Baseline and immediately following the 1-week intervention
Postural stability assessed by the number of balance errors performed in double-leg, single-leg, and tandem stance conditions. Lower scores indicate better balance performance.
Baseline and immediately following the 1-week intervention
Core muscle endurance (Prone plank test)
Time Frame: Baseline and immediately following the 1-week intervention
Core endurance assessed by the duration the participant maintains the correct prone plank position. Longer duration indicates better core endurance.
Baseline and immediately following the 1-week intervention
Tampa Scale for Kinesiophobia (TSK)
Time Frame: Baseline and immediately following the 1-week intervention
Kinesiophobia assessed using the Tampa Scale for Kinesiophobia. Higher scores indicate greater fear of movement.
Baseline and immediately following the 1-week intervention
Visual Analog Scale (VAS) for pain
Time Frame: Baseline and immediately following the 1-week intervention
Pain intensity assessed using a 100-mm visual analog scale, with higher scores indicating greater pain intensity.
Baseline and immediately following the 1-week intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 15, 2025

Primary Completion (Actual)

October 26, 2025

Study Completion (Actual)

January 12, 2026

Study Registration Dates

First Submitted

April 29, 2026

First Submitted That Met QC Criteria

May 6, 2026

First Posted (Actual)

May 13, 2026

Study Record Updates

Last Update Posted (Actual)

May 13, 2026

Last Update Submitted That Met QC Criteria

May 6, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • PAU-FTR-GG-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neuroathletic Training

Clinical Trials on neuroathletic training

Subscribe